Molecular deletion analysis in Duchenne muscular dystrophy

Area of Science:

• Genetics
• Molecular Biology
• Neurology

Background:

• X-linked muscular dystrophies, including Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD), are genetic disorders affecting muscle function.
• Molecular genetic testing is essential for diagnosing these conditions and identifying carriers.

Purpose of the Study:

• To investigate the frequency of molecular deletions in patients with X-linked muscular dystrophy.
• To evaluate the utility of specific DNA probes for detecting these deletions.
• To assess the clinical relevance of deletions in Duchenne muscular dystrophy.

Main Methods:

• Analysis of 165 unrelated patients with X-linked muscular dystrophy (117 DMD, 48 BMD).
• Molecular deletion detection using DNA probes pERT87 and XJ1.1.
• Family studies for carrier status identification.

Main Results:

• Molecular deletions were identified in 9 out of 117 Duchenne muscular dystrophy cases (8%).
• No deletions were detected in the 48 Becker muscular dystrophy patients.
• No cytogenetic abnormalities were found, and no clear clinical differences distinguished deletion-positive from deletion-negative DMD cases.
• Carrier status in females was unequivocally identified in families with deletions.

Conclusions:

• Molecular deletions are present in a subset of Duchenne muscular dystrophy patients.
• The DNA probes pERT87 and XJ1.1 are valuable tools for detecting deletions, with combined use recommended for comprehensive analysis.
• Deletion detection aids in carrier identification for at-risk families.